Verana Health, a life sciences product development platform formerly known as DigiSight, has received funding in a GV-led round featuring GE Ventures.
GV, the corporate venturing subsidiary of internet technology group Alphabet, has led a $30m series C round for Verana Health, the US-based creator of a life science product development platform.
GE Ventures, the corporate venture capital vehicle for industrial product maker General Electric, also took part in the round, along with investment firm Lagunita Biosciences, VC firm Biomatics Capital and private investor Brook Byers.
Verana has built a platform that utilises regulatory-grade datasets from the world’s largest clinical ophthalmology database…
